{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T14:27:28Z","timestamp":1770992848160,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1989,6,1]],"date-time":"1989-06-01T00:00:00Z","timestamp":612662400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother. Pharmacol."],"published-print":{"date-parts":[[1989,6]]},"DOI":"10.1007\/bf00435834","type":"journal-article","created":{"date-parts":[[2004,11,11]],"date-time":"2004-11-11T04:58:10Z","timestamp":1100149090000},"page":"348-352","source":"Crossref","is-referenced-by-count":6,"title":["Phase I study of methylacetylenic putrescine, an inhibitor of polyamine biosynthesis"],"prefix":"10.1007","volume":"23","author":[{"given":"Michael A.","family":"Cornbleet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Kingsnorth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy P.","family":"Tell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus D.","family":"Haegele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Marie","family":"Joder-Ohlenbusch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F.","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1200\/JCO.1984.2.2.124","volume":"2","author":"MD Abeloff","year":"1984","unstructured":"Abeloff MD, Slavik M, Luk GD, Griffin CA, Hermann J, Blanc O, Sjoerdsma A, Baylin SB (1984) Phase I trial and pharmacolinetic studies of ?-difluoromethylornithine, an inhibitor of polyamine biosynthesis. J Clin Oncol 2: 124","journal-title":"J Clin Oncol"},{"key":"CR2","first-page":"4972","volume":"44","author":"J Bartholeyns","year":"1984","unstructured":"Bartholeyns J, Mamont P, Casara P (1984) Antitumor properties of (2R,5R)-6-Heptyne-2,5 diamine, a new potent enzymeactivated irreversible inhibitor of ornithine decarboxylase, in rodents. Cancer Res 44: 4972","journal-title":"Cancer Res"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0006-291X(83)90406-0","volume":"116","author":"C Danzin","year":"1983","unstructured":"Danzin C, Casara P, Claverie N, Metcalf BW, Jung MF (1983) (2R,5R)-6-Heptyne-2,5 diamine, an extremely potent inhibitor of mammalian ornithine decarboxylase. Biochem Biophys Res Commun 116: 237","journal-title":"Biochem Biophys Res Commun"},{"key":"CR4","first-page":"183","volume":"16","author":"EJ Freireich","year":"1962","unstructured":"Freireich EJ, Frei E III, Karan M (1962) Methylglyoxal-bis (guanylhydrazone): a new agent active against acute myelocytic leukaemia. Cancer Chemother Rep 16: 183","journal-title":"Cancer Chemother Rep"},{"key":"CR5","first-page":"890","volume":"47","author":"KD Haegele","year":"1987","unstructured":"Haegele KD, Splinter TAW, Romijn JC, Schechter PJ, Sjoerdsma A (1987) Decarboxylated-S-adenosylmethionine excretion: a biochemical marker of ornithine decarboxylase inhibition by ?-difluoromethylornithine. Cancer Res 47: 890","journal-title":"Cancer Res"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0304-4165(81)90149-5","volume":"677","author":"E Hollta","year":"1981","unstructured":"Hollta E, Korpela H, Hovi T (1981) Several inhibitors of ornithine and adenosylmethionine decarboxylases may also have antiproliferative effects unrelated to polyamine depletion. Biochem Biophys Acta 677: 90","journal-title":"Biochem Biophys Acta"},{"key":"CR7","first-page":"76","volume":"68","author":"A Kingsnorth","year":"1986","unstructured":"Kingsnorth A (1986) The chemotherapeutic potential of polyamine antimetabolites. Ann R Coll Surg Engl 68: 76","journal-title":"Ann R Coll Surg Engl"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00179433","volume":"3","author":"AM Maddox","year":"1985","unstructured":"Maddox AM, Keating MJ, McCredie KE, Estey E, Freireich EJ (1985) Phase I evaluation of intravenous difluoromethylornithine ? a polyamine inhibitor. Invest New Drugs 3: 287","journal-title":"Invest New Drugs"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1432-1033.1982.tb06559.x","volume":"123","author":"PS Mamont","year":"1982","unstructured":"Mamont PS, Danzin C, Wagner J, Siat M, Joder-Ohlenbusch A-M, Claverie N (1982) Accumulation of decarboxylated S-adenosyl-L-methionine in mammalian cells as a consequence of the inhibition of putrescine biosynthesis. Eur J Biochem 123: 499","journal-title":"Eur J Biochem"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47: 207","journal-title":"Cancer"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1152\/ajpcell.1982.243.5.C212","volume":"243c","author":"AE Pegg","year":"1982","unstructured":"Pegg AE, McCann P (1982) Polyamine metabolism and function. Am J Physiol 243c: 212","journal-title":"Am J Physiol"},{"key":"CR12","first-page":"1148","volume":"46","author":"PJ Pera","year":"1986","unstructured":"Pera PJ, Kramer DL, Sufrin JR, Porter CW (1986) Comparison of the biological effects of four irreversible inhibitors of ornithine decarboxylase in two murine lymphocytic leukemia cell lines. Cancer Res 46: 1148","journal-title":"Cancer Res"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0169-4758(86)90087-6","volume":"2","author":"PJ Schechter","year":"1986","unstructured":"Schechter PJ, Sjoerdsma A (1986) Difluoromethylornithine in the treatment of African trypanosomiasis. Parasitol Today 2: 223","journal-title":"Parasitol Today"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0378-4347(00)84307-8","volume":"221","author":"N Seiler","year":"1980","unstructured":"Seiler N, Kn\u00f6dgen B (1980) High-performance liquid chromatographic procedure for the simultaneous determination of the natural polyamines and their monoacetyl derivatives. J Chromatogr 221: 227","journal-title":"J Chromatogr"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/clpt.1984.33","volume":"35","author":"A Sjoerdsma","year":"1984","unstructured":"Sjoerdsma A, Schechter PJ (1984) Chemotherapeutic implications of polyamine biosynthesis inhibition. Clin Pharmacol Ther 35: 287","journal-title":"Clin Pharmacol Ther"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1432-1033.1974.tb03566.x","volume":"45","author":"RD Spencer","year":"1974","unstructured":"Spencer RD, Weben G, Tolman GL, Barrio JR, Leonard MJ (1974) Species responsible for the fluorescence of 1:N6-ethenoadenosine. Eur J Biochem 45: 425","journal-title":"Eur J Biochem"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/0003-2697(86)90036-9","volume":"154","author":"J Wagner","year":"1986","unstructured":"Wagner J, Hirth Y, Claverie N, Danzin C (1986) A sensitive high-performance liquid chromatographic procedure with fluorometric detection for the analysis of decarboxylated S-adenosylmethionine and analogs in urine samples. Anal Biochem 154: 604","journal-title":"Anal Biochem"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1200\/JCO.1983.1.1.52","volume":"1","author":"RP Warrell","year":"1983","unstructured":"Warrell RP, Burchenal JH (1983) Methylglyoxal-bis(guanylhydrazone) (MGBG). Current status and future prospects. J Clin Oncol 1: 52","journal-title":"J Clin Oncol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0006-291X(72)90661-4","volume":"46","author":"HG Williams-Ashman","year":"1972","unstructured":"Williams-Ashman HG, Scherone A (1972) MGBG as a potent inhibitor of mammalian and yeast S-adenosylmethionine decarboxylases. Biochem Biophys Res Commun 46: 288","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00435834.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00435834\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00435834","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T19:11:30Z","timestamp":1554837090000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00435834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,6]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1989,6]]}},"alternative-id":["BF00435834"],"URL":"https:\/\/doi.org\/10.1007\/bf00435834","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,6]]}}}